Modern Methods for Analysis of Antiepileptic Drugs in the Biological Fluids for Pharmacokinetics, Bioequivalence and Therapeutic Drug Monitoring

다국어 초록 (Multilingual Abstract)

Epilepsy is a chronic disease occurring in approximately 1.0% of the world’s population. About 30% of the epileptic patients treated with availably antiepileptic drugs (AEDs) continue to have seizures and are considered therapy-resistant or refractory patients. The ultimate goal for the use of AEDs is complete cessation of seizures without side effects. Because of a narrow therapeutic index of AEDs, a complete understanding of its clinical pharmacokinetics is essential for understanding of the pharmacodynamics of these drugs. These drug concentrations in biological fluids serve as surrogate markers and can be used to guide or target drug dosing. Because early studies demonstrated clinical and/or electroencephalographic correlations with serum concentrations of several AEDs, It has been almost 50 years since clinicians started using plasma concentrations of AEDs to optimize pharmacotherapy in patients with epilepsy. Therefore, validated analytical method for concentrations of AEDs in biological fluids is a necessity in order to explore pharmacokinetics, bioequivalence and TDM in various clinical situations. There are hundreds of published articles on the analysis of specific AEDs by a wide variety of analytical methods in biological samples have appears over the past decade. This review intends to provide an updated, concise overview on the modern method development for monitoring AEDs for pharmacokinetic studies, bioequivalence and therapeutic drug monitoring.

참고문헌 (Reference)

• 1 USP Drug Information, "Volume I: Drug Information for the Health Care Professional. 24th ed" Greenwood Village Co 709-, 2004
• 2 Kalviainen R, "Visual field defects with vigabatrin: Epidemiology and therapeutic implications" 15 : 217-230, 2001
• 3 Grant SM, "Vigabatrin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control" 41 : 889-926, 1991
• 4 Rey E, "Vigabatrin. Clinical pharmacokinetics" 28 : 267-278, 1992
• 5 Cloyd JC, "Vaproic acid pharmacokinetics in children. IV. Effects of age and antiepileptic drugs on protein binding and intrinsic clearance" 53 : 22-29, 1993
• 6 Sugimoto T, "Valproate metabolites in high-dose valproate plus phenytoin therapy" 37 : 1200-1203, 1996
• 7 Chen S, "Validation of liquid-liquid extraction followed by flow-injection negative ion electrospray mass spectrometry assay to topiramate in human plasma" 15 : 159-163, 2001
• 8 Biddlecombe RA, "Validation of a radioimmunoassay for the determination of human plasma concentrations of lamotrigine" 8 : 691-694, 1990
• 9 Kishore P, "Validated high performance liquid chromatographic method for simultaneous determination of phenytoin, phenobarbital and carbamazepine in human serum" 53 : 763-768, 2003
• 10 Park JH, "Validated LC-MS/MS method for quantification of gabapentin in human plasma: application to pharmacokinetic and bioequivalence studies in Korean volunteers" 21 : 829-835, 2007
• 11 Jalalizadeh H, "Validated HPLC method for the determination of gabapentin in human plasma using pre-column derivatization with 1-fluoro-2,4- dinitrobenzene and its application to a pharmacokinetic study" 854 : 43-47, 2007
• 12 Kutt H, "Usefulness of blood levels of antiepileptic drugs" 31 : 283-288, 1974
• 13 Treston AM, "Urinary metabolites of phenobarbitone, primidone, and their N-methyl and N-ethyl derivatives in humans" 22 : 385-394, 1992
• 14 Chen SH, "Trace analysis of ethosuximide in human plasma with a chemically removable derivatizing reagent and high-performance liquid chromatography" 729 : 111-117, 1999
• 15 Sachdeo RC, "Topiramate: Clinical profile in epilepsy" 34 : 335-346, 1998
• 16 Contin M, "Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs" 24 : 332-337, 2002
• 17 Schachter SC, "Tiagabine" 40 : 17-22, 1999
• 18 Tomson T, "Therapeutic monitoring of the new antiepileptic drugs" 55 : 697-705, 2000
• 19 Eadie MJ, "Therapeutic drug monitoring-antiepileptic drugs" 46 : 185-193, 1998
• 20 Johannessen SI, "Therapeutic drug monitoring of the newer antiepileptic drugs" 25 : 347-363, 2003
• 21 Neels HM, "Therapeutic drug monitoring of old and newer anti-epileptic drugs" 42 : 1228-1255, 2004
• 22 Theurillat R, "Therapeutic drug monitoring of lamotrigine using capillary electrophoresis. Evaluation of assay performance and quality assurance over a 4-year period in the routine arena" 979 : 353-368, 2002
• 23 Benetello P, "Therapeutic drug monitoring of lamotrigine in patients suffering from resistant partial seizures" 48 : 200-203, 2002
• 24 Lancelin F, "Therapeutic Drug Monitoring of Levetiracetam by High- Performance Liquid Chromatography With Photodiode Array Ultraviolet Detection: Preliminary Observations on Correlation Between Plasma Concentration and Clinical Response in Patients With Refractory Epilepsy" 29 : 576-583, 2007
• 25 Labbate LA, "The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma" 14 : 274-276, 1994
• 26 Riikonen R, "The latest on infantile spasms" 18 : 91-95, 2005
• 27 Fattore C, "The influence of old age and enzyme inducing comedication on the pharmacokinetics of vaproic acid at steady-state: a case-matched evaluation based on therapeutic drug monitoring data" 70 : 153-160, 2006
• 28 Irving RC, "The detection of sedatives in hair and nail samples using tandem LC-MS-MS" 166 : 58-67, 2007
• 29 Berry DJ, "The absorption of gabapentin following high dose escalation" 12 : 28-36, 2003
• 30 Rating D, "Teratogenic and pharmacokinetic studies of primidone during pregnancy and in the offspring of epileptic women" 71 : 301-311, 1982
• 31 de Collongue-Poyet B, "Study of conformational effects of recombinant interferon-γ adsorbed on a non-porous reversed-phase silica support" 664 : 155-161, 1995
• 32 Franco V, "Stereoselective determination of vigabatrin enantiomers in human plasma by high performance liquid chromatography using UV detection" 854 : 37-63, 2007
• 33 Sachdeo RC, "Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy" 37 : 774-780, 1996
• 34 Salem AA, "Spectrophotometric and fluorimetric determination of diazepam, bromazepam and clonazepam in pharmaceutical and urine samples" 60 : 771-780, 2004
• 35 Rezaei Z, "Simultaneous spectrophotometric determination of carbamazepine and phenytoin in serum by PLS regression and comparison with HPLC" 65 : 21-28, 2005
• 36 Gaillard Y, "Simultaneous screening and quantitation of alpidem, zolpidem, buspirone and benzodiazepines by dual-channel gas chromatography using electron-capture and nitrogen-phosphorus detection after solid-phase extraction" 622 : 197-208, 1993
• 37 Lanças FM, "Simultaneous plasma lamotrigine analysis with carbamazepine, carbamazepine- 10,11-epoxide, primidone, phenytoin, Phenobarbital, and PEMA by micellar electrokinetic capillary chromatography (MECC)" 27 : 304-308, 2003
• 38 Kabra PM, "Simultaneous measurement of phenobarbital, phenytoin, primidone, ethosuximide, and carbamazepine in serum by high-performance liquid chromatography" 23 : 1284-1288, 1977
• 39 Ou CN, "Simultaneous measurement of ethosuximide, primidone, phenobarbital, phenytoin, carbamazepine, and their bioactive metabolites by liquid chromatography" 30 : 1667-1670, 1984
• 40 Contin M, "Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy" 828 : 113-117, 2005
• 41 Saracino MA, "Simultaneous high-performance liquid chromatographic determination of olanzapine and lamotrigine in plasma of bipolar patients" 29 : 773-780, 2007
• 42 Yoshida T, "Simultaneous determination of zonisamide, carbamazepine and carbamazepine-10,11-epoxide in infant serum by high- performance liquid chromatography" 41 : 1386-1390, 2006
• 43 Juergens U, "Simultaneous determination of zonisamide and none other antiepileptic drugs and metabolites in serum. A comparison of microbore and conventional high-performance liquid chromatography" 385 : 233-240, 1987
• 44 Tanaka E, "Simultaneous determination of twelve benzodiazepines in human serum using a new reversed-phase chromatographic column on a 2-microns porous microspherical silica gel" 682 : 173-178, 1996
• 45 Moriyama M, "Simultaneous determination of primidone and its active metabolites in rat plasma by high-performance liquid chromatography using a solid-phase extraction technique" 83 : 1751-1753, 1994
• 46 Bhatti MM, "Simultaneous determination of phenytoin, carbamazepine, and 10,11-carbamazepine epoxide in human serum by high-performance liquid chromatography with ultra-violet detection" 16 : 1233-1240, 1998
• 47 Zhong Y, "Simultaneous determination of mycophenolic acid and valproic acid based on derivatization by high-performance liquid chromatography with fluorescence detection" 20 : 319-326, 2006
• 48 Ceccato A, "Simultaneous determination of methylphenobarbital enantiomers and phenobarbital in human plasma by on-line coupling of an achiral precolumn to a chiral liquid chromatographic column" 819 : 143-153, 1998
• 49 Patil KM, "Simultaneous determination of lamotrigine, phenobarbitone, carbamazepine and phenytoin in human serum by high-performance liquid chromatography" 39 : 181-186, 2005
• 50 Levert H, "Simultaneous determination of four antiepileptic drugs in serum by high-performance liquid chromatography" 16 : 19-24, 2002
• 51 Romanyshyn LA, "Simultaneous determination of felbamate, primidone, Phenobarbital, carbamazepine, two carbamazepine metabolites, phenytoin and one phenytoin metabolite in human plasma by high-performance liquid chromatography" 16 : 90-99, 1994
• 52 Nakamura M, "Simultaneous determination of benzodiazepines and their metabolites in human serum by liquid chromatography- tandem mass spectrometry using a high-resolution octadecyl silica column compatible with aqueous compounds" 23 : 357-364, 2009
• 53 Budakova L, "Simultaneous determination of antiepileptic drugs and their two active metabolites by HPLC" 31 : 1-8, 2008
• 54 Juergens U, "Simultaneous determiantion of zonisamide and nine other anti-epileptic drugs and metabolites in serum: A comparison of microbore and conventional high-performance liquid chromatography" 385 : 233-240, 1987
• 55 Contin M, "Simple and validated HPLC-UV analysis of levetiracetam in deproteinized plasma of patients with epilepsy" 18 : 129-132, 2008
• 56 Kunicki PK, "Simple and sensitive high-performance liquid chromatographic method for the determination of 1,5-benzodiazepine clobazam and its active metabolite N-desmethylclobazam in human serum and urine with application to 1,4-benzodiazepines analysis" 750 : 41-49, 2001
• 57 Lin MC, "Simple and sensitive fluorimetric liquid chromatography method for the determination of valproic acid in plasma" 810 : 169-172, 2004
• 58 Furuno K, "Simple and sensitive assay of zonisamide in human serum by high-performance liquid chromatography using a solid-phase extraction technique" 656 : 456-459, 1994
• 59 Cacas MN, "Simple and rapid micellar electrokinetic capillary chromatographic method for simultanoeus determination of four antiepileptics in human serum" 18 : 608-612, 2004
• 60 Contin M, "Simple and rapid liquid chromatographic-turbo ion spray mass spectrophotometric determination of topiramate in human plasma" 761 : 133-137, 2001
• 61 Yamashita S, "Simple and rapid analysis of lamotrigine, a novel antiepileptic, in human serum by high- performance liquid chromatography using a solid-phase extraction technique" 670 : 354-357, 1995
• 62 Bhatt M, "Shivprakash. Development of a high- throughput method for the determination of ethosuximide in human plasma by liquid chromatography mass spectrometry" 878 : 1605-1610, 2010
• 63 Shihabi ZK, "Serum lamotrigine analysis by capillary electrophoresis" 683 : 119-123, 1996
• 64 Dreifuss FE, "Serum clonazepam concentrations in children with absence seizures" 23 : 255-258, 1975
• 65 Westley IS, "Seradyn Quantitative Microsphere System Lamotrigine Immunoassay on a Hitachi 911 Analyzer Compared With HPLC-UV" 30 : 634-637, 2008
• 66 Bahrami G, "Sensitive high-performance liquid chromatographic quantitation of gabapentin in human serum using liquid-liquid extraction and pre-column derivatization with 9-fluorenylmethyl chloroformate" 835 : 123-126, 2006
• 67 Darius J, "Sensitive capillary gas chromatographic-mass spectrometric method for the therapeutic drug monitoring of vaproic acid and seven of its metabolites in human serum. Application of the assay for a group of pediatric epileptics" 656 : 343-351, 1994
• 68 Maresova V, "Screening and semiquantitative analysis of drugs and drugs of abuse in human serum samples using gas chromatography-mass spectrometry" 29 : 749-754, 2008
• 69 Mecarelli O, "Saliva and serum levetiracetam concentrations in patients with epilepsy" 29 : 313-318, 2007
• 70 Perucca E, "Role of vaproate across the ages. Treatment of epilepsy in the elderly" 184 : 28-37, 2006
• 71 Vermeij TA, "Robust isocratic high performance liquid chromatographic method for simultaneous determination of seven antiepileptic drugs including lamotrigine, oxcarbazepine and zonisamide in serum after solid-phase extraction" 857 : 40-46, 2007
• 72 Wilder BJ, "Review of valproate monotherapy in the treatment of generalized tonic-clonic seizures" 84 : 7-13, 1988
• 73 Reife RA, "Relationship of steady-state plasma topiramate (TPM) concentration to clinical efficacy and tolerability" 36 : 152-, 1995
• 74 Gidal BE, "Relationship between vaproic acid dosage, plasma concentration and clearance in adult monotherapy patients with epilepsy" 20 : 215-219, 1995
• 75 Tisdale JE, "Relationship between serum concentration and dose of vaproic acid during monotherapy in adult outpatients" 14 : 416-423, 1992
• 76 Shah HJ, "Rapid quantification of lamotrigine in human plasma by two LC systems connected with tandem MS" 48 : 375-381, 2010
• 77 Solden SJ, "Rapid micromethod for measuring anticonvulsant drugs in serum by high-performance liquid chromatography" 22 : 856-859, 1976
• 78 la Marca G, "Rapid assay of topiramate in dried blood spots by a new liquid chromatography-tandem mass spectrometric method" 48 : 1392-1396, 2008
• 79 Paw B, "Rapid and simple high- performance liquid chromatographic determination of felbamate in serum" 60 : 339-342, 2003
• 80 Hansen RJ, "Rapid and sensitive LC-MS/MS method for determination of felbamate in mouse plasma and tissues and human plasma" 878 : 3432-3436, 2010
• 81 Smithers JA, "Quantitative analysis of vigabatrin in plasma and urine by reversed-phase high- performance liquid chromatography" 341 : 232-238, 1985
• 82 Knapp J, "Quantitation of clobazam in human plasma using high-performance liquid chromatography" 37 : 145-149, 1999
• 83 Tiscione NB, "Quantitation of benzodiazepines in whole blood by electron impact-gas chromatography-mass spectrometry" 32 : 644-652, 2008
• 84 Marin SJ, "Quantitation of benzodiazepines in urine, serum, plasma, and meconium by LC-MS-MS" 32 : 491-498, 2008
• 85 Cheng H, "Quantification of vaproic acid and its metabolite 2-propyl-4-pentenoic acid in human plasma using HPLC-MS/MS" 850 : 206-212, 2007
• 86 Nirogi RV, "Quantification of oxcarbazeipine and its active metabolite 10-hydroxycarbazepine in human plasma by high-performance liquid chromatography" 56 : 517-523, 2006
• 87 Matar KM, "Quantification of levetiracetam in human plasma by liquid chromatography-tandem mass spectrometry: Application to therapeutic drug monitoring" 48 : 822-828, 2008
• 88 Queiroz RH, "Quantification of carbamazepine, carbamazepine-10,11-epoxide, phenytoin and phenobarbital in plasma samples by stir bar-sorptive extraction and liquid chromatography" 48 : 428-834, 2008
• 89 Thompson CD, "Quantification in patient urine samples of felbamate and three metabolites: acid carbamate and two mercapturic acids" 40 : 769-776, 1999
• 90 Fröscher W, "Prospective study on concentration-efficacy and concentration-toxicity: correlations with lamotrigine serum levels" 4 : 49-56, 2002
• 91 Lhatoo S, "Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy" 41 : 338-341, 2000
• 92 Ermakov AN, "Polarized fluoroimmunoanalysis of phenobarbital using the TD(x) analyzer from "Abbott" laboratories" 39 : 59-63, 1993
• 93 Johannessen SI, "Plasma drug concentration monitoring of anticonvulsants. Practical guidelines" 7 : 349-365, 1997
• 94 Sackellares JC, "Pilot study of zonisamide (1,2-benzisoxazole-3-methanesulfonamide) in patients with refractory partial seizures" 26 : 206-211, 1985
• 95 Tozer TN, "Phenytoin, In Applied pharmacokinetics: principles of therapeutic drug monitoring. 3rd ed." Applied Therapeutics 25-, 1992
• 96 Winter ME, "Phenytoin, In Applied pharmacokinetics & Pharmacodynamic: principles of therapeutic drug monitoring. 4rd ed." LWW 464-, 2006
• 97 Tutor-Crespo MJ, "Phenytoin immunoassay measurements in serum samples from patients with renal insufficiency: comparison with high-performance liquid chromatography" 21 : 119-123, 2007
• 98 Gustavson LE, "Pharmacokinetics of tiagabine, a gamma-aminobutyric acid-uptake inhibitor, in healthy subjects after single and multiple doses" 36 : 605-611, 1995
• 99 Rey E, "Pharmacokinetics of the individual enantiomers of vigabatrin (γ-vinyl GABA) in epileptic children" 30 : 253-257, 1990
• 100 Berlin A, "Pharmacokinetics of the anticonvulsant drug clonazepam evaluated from single oral and intravenous doses and by repeated oral administration" 9 : 155-159, 1975
• 101 Sjö O, "Pharmacokinetics and side-effects of clonazepam and its 7-amino-metabolite in man" 8 : 249-254, 1975
• 102 Anderson GD, "Pharmacokinetic, Pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs" 30 : 173-180, 2008
• 103 Bialer M, "Pharmacokinetic interactions of topiramate" 43 : 763-800, 2004
• 104 Glauser TA, "Oxcarbazepine in the Treatment of Epilepsy" 21 : 904-919, 2001
• 105 Flesh G, "Overview of the clinical pharmacokinetics of oxcarbazepine" 24 : 185-203, 2004
• 106 Fay MA, "Oral absorption kinetics of levetiracetam: the effect of mixing with food or enteral nutrition formulas" 27 : 594-598, 2005
• 107 Patsalos PN, "New antiepileptic drugs" 36 : 10-19, 1999
• 108 Zhao H, "Multiwalled carbon nanotubes as a solid-phase extraction adsorbent for the determination of three barbiturates in pork by ion trap gas chromatography-tandem mass spectrometry (GC/MS/MS) following microwave assisted derivatization" 586 : 399-406, 2007
• 109 Shimoyama R, "Monitoring of zonisamide in human breast milk and maternal plasma by solid-phase extraction HPLC method" 13 : 370-372, 1999
• 110 Külpmann WR, "Monitoring of therapeutic serum concentrations of antiepileptic drugs by a newly developed gas chromatographic procedure and enzyme immunoassay (EMIT): a comparative study" 19 : 249-258, 1981
• 111 Makino K, "Micellar electrokinetic capillary chromatography for therapeutic drug monitoring of zonisamide" 695 : 417-425, 1997
• 112 Baillie TA, "Metabolism of valproate to hepatotoxic intermediates" 14 : 122-125, 1992
• 113 Porter RJ, "Mechanisms of action of new antiepileptic drugs" 30 : 29-34, 1989
• 114 Rho JM, "Mechanism of action of the anticonvulsant felbamate:opposing effects on N-methyl-D- aspartate and gamma-aminobutyric acid A receptors" 35 : 229-234, 1994
• 115 De Carvalho D, "Measurement of plasma clonazepam for therapeutic control: a comparison of chromatographic methods" 13 : 55-63, 1991
• 116 Rifai N, "Measurement of felbamate by wide-bore capillary gas chromatography and flame ionization detection" 40 : 745-748, 1994
• 117 Christofides JA, "Measurement of anticonvulsants in serum by reversed-phase ion-pair liquid chromatography" 26 : 499-501, 1980
• 118 Breton H, "Liquid chromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma" 828 : 80-90, 2005
• 119 Christensen J, "Liquid chromatography tandem mass spectrometry assay for topiramate in plasma and cerbrospinal fluid: validation and comparison with fluorescence-polarization immunoassay" 24 : 658-664, 2002
• 120 Matar KM, "Liquid chromatographic determination of six antiepileptic drugs and two metabolites in microsamples of human plasma" 21 : 559-566, 1999
• 121 Nash EM, "Levetiracetam" 58 : 1195-1199, 2001
• 122 Fitton A, "Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy" 50 : 691-713, 1995
• 123 Morris RG, "Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service" 46 : 547-551, 1998
• 124 Dasgupta A, "Lamotrigine analysis in plasma by gas chromatography-mass spectrometry after conversion to a tert-butyldimethylsilyl derivative" 693 : 101-107, 1997
• 125 Johannessen SI, "Laboratory monitoring of antiepileptic drugs, In Methods of determination of antiepileptic drugs in antiepileptic drugs. 4th ed" LWW 103-, 2002
• 126 Levert H, "LC determination of oxcarbazepine and its active metabolite in human serum" 28 : 517-525, 2002
• 127 Haegele KD, "Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S-enantiomer" 40 : 581-586, 1986
• 128 Poquette MA, "Isothermal gas chromatographic method for the rapid determination of felbamate concentration in human serum" 17 : 168-173, 1995
• 129 Marquet P, "Is LC-MS suitable for a comprehensive screening of drugs and poisons in clinical toxicology" 24 : 125-133, 2002
• 130 Sirgo MA, "Interpretation of serum phenytoin concentrations in uremia is assay- dependent" 34 : 1250-1251, 1984
• 131 Williams J, "Interlaboratory variability in the quantification of new generation antiepileptic drugs based on external quality assessment data" 44 : 40-45, 2003
• 132 Roller SG, "Interaction between human serum albumin and the felbamate metabolites 4-Hydroxy-5-phenyl-[1,3]oxazinan-2-one and 2-phenylpropenal" 15 : 815-824, 2002
• 133 Gidal BE, "Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability" 40 : 123-127, 2000
• 134 Yukawa E, "Influence of age and comedication on steady-state clonazepam serum level-dose ratios in Japanese epileptic patients" 26 : 375-379, 2001
• 135 Vuckovic D, "In vivo solid-phase microextration for single rodent pharmacokinetics studies of carbamazepine and carbamazepine-10, 11-epoxide in mice" 60 : 1060-1068, 2010
• 136 Patsalos PN, "In situ metabolism of levetiracetam in blood of patients with epilepsy" 47 : 1818-1821, 2006
• 137 Le Quellec C, "Improved selectivity for high-performance liquid chromatographic determination of clonazepam in plasma of epileptic patients" 719 : 227-233, 1998
• 138 Dhar AK, "Improved gas chromatographic procedure for the determination of clonazepam levels in plasma using a nitrogen-sensitive detector" 222 : 203-211, 1981
• 139 Sailstad JM, "Immunofluorometric assay for lamotrigine (Lamictal) in human plasma" 13 : 433-442, 199
• 140 Maurer H, "Identification and differentiation of benzodiazepines and their metabolites in urine by computerized gas chromatography-mass spectrometry" 422 : 85-101, 1987
• 141 Subramanian M, "High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry" 30 : 347-356, 2008
• 142 Wirth HJ, "High-performance liquid chromatography of amino acids, peptides and proteins. CIX. Investigations on the relation between the ligand density of cibacron blue immobilized porous and non-porous sorbents and protein-binding capacities and association constants" 550 : 383-395, 1991
• 143 Gustavson LE, "High-performance liquid chromatographic procedure for the determination of tiagabine concentrations in human plasma using electrochemical detection" 574 : 313-318, 1992
• 144 El Mahjoub A, "High-performance liquid chromatographic method for the determination of benzodiazepines in plasma or serum using the column-switching technique" 742 : 381-390, 2000
• 145 Pucci V, "High-performance liquid chromatographic determination of Levetiracetam in human plasma: comparison of different sample clean-up procedures" 18 : 37-44, 2004
• 146 Vermeij TA, "High-performance liquid chromatographic and megabore gas-liquid chromatographic determination of levetiracetam (ucb L059) in human serum after solid-phase extraction" 662 : 134-139, 1994
• 147 Vermeij TA, "High-performance liquid chromatographic analysis of vigabatrin enantiomers in human serum by precolumn derivatization with o-phthaldialdehyde- N-acetyl-L-cysteine and fluorescence detection" 716 : 233-238, 1998
• 148 Chen T, "High-peformance liquid chromatographic resolution of enantiomers of γ-vinyl-γ-aminobutyric acid" 314 : 495-498, 1984
• 149 Kishore P, "HPLC determination of valproic acid in human serum" 58 : 378-380, 2003
• 150 Gambelunghe C, "Gas chromatography-tandem mass spectrometry analysis of gabapentin in serum" 19 : 63-67, 2005
• 151 Chollet DF, "Gas chromatography-mass spectrometry assay method for the therapeutic drug monitoring of the antiepileptic drug tiagabine" 21 : 641-646, 1999
• 152 von Unruh GE, "Gas chromatographic assay for oxcarbazepine and its main metabolites in plasma" 345 : 67-76, 1985
• 153 Ifa DR, "Gabapentin quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. Application to bioequivalence study" 36 : 188-194, 2001
• 154 Gidal BE, "Gabapentin bioavailability: effect of dose and frequency of administration in adult patients with epilepsy" 31 : 91-99, 1998
• 155 Hsieh CY, "Fluorescent high- performance liquid chromatographic analysis of vigabatrin enantiomers after derivatizing with naproxen acyl chloride" 1178 : 166-170, 2008
• 156 Palmer KJ, "Felbamate: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy" 45 : 1041-1065, 1993
• 157 Shihabi ZK, "Felbamate measured in serum by two methods: HPLC and capillary electrophoresis" 40 : 1904-1908, 1994
• 158 Pellock JM, "Felbamate in epilepsy therapy; evaluating the risks" 3 : 225-239, 1999
• 159 Chollet DF, "Fast isocratic high-performance liquid chromatographic assay method for the simultaneous determination of gabapentin and vigabatrin in human serum" 746 : 311-314, 2000
• 160 Gunnar T, "Fast gas chromatography- negative-ion chemical ionization mass spectrometry with microscale volume sample preparation for the determination of benzodiazepines and alpha-hydroxy metabolites, zaleplon and zopiclone in whole blood" 41 : 741-754, 2006
• 161 Roberts WL, "Falsely increased immunoassay measurements of total and unbound phenytoin in critically ill uremic patients receiving fosphenytoin" 45 : 829-837, 1999
• 162 Contin M, "Evidence of polymorphism CYP2C19 involvement in the human metabolism of N-desmethylclobazam" 24 : 737-741, 2002
• 163 Tosoni S, "Evaluation of valproic acid fluoroimmunoassay and comparison with a gas liquid chromatographic method" 7 : 236-238, 1985
• 164 Steijns LS, "Evaluation of fluorescence polarization assays for measuring vaproic acid, phenytoin, carbamazepine and phenobarbital in serum" 24 : 432-435, 2002
• 165 Wilson JF, "Evaluation of assay techniques for the measurement of antiepileptic drugs in serum: a study based on external quality assurance measurements" 11 : 185-195, 1989
• 166 Graves NM, "Epilepsy, In Pharmacotherapy: A Pathophysiologic Approach. 6th ed." McGraw-Hill 1023-, 2005
• 167 Knight D, "Enzyme immunoassay of phenobarbital, phenytoin, primidone, carbamazepine and theophylline with the Abbott VP Bichromatic Analyzer" 14 : 14-15, 1981
• 168 Isoherranen N, "Enantioselective analysis of levetiracetam and its enantiomer R-α-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detection" 745 : 325-332, 2000
• 169 Brodies MJ, "Drug therapy-antiepileptic drugs" 334 : 168-175, 1996
• 170 Chiron C, "Drug therapy for West’s syndrome" 497 : 51-56, 2002
• 171 Greiner-Sosanko E, "Drug monitoring: simultaneous analysis of lamotrigine, oxcarbazepine, 10-hydroxycarbazepine, and zonisamide by HPLC-UV and a rapid GC method using a nitrogen-phosphorus detector for levetiracetam" 45 : 616-622, 2007
• 172 Tang PH, "Drug monitoring and toxicology: a simple procedure for the monitoring of felbamate by HPLC-UV detection" 32 : 373-378, 2008
• 173 Juenke J, "Drug monitoring and toxicology: A procedure for the monitoring of levetiracetam and zonisamide by HPLC-UV" 30 : 27-30, 2006
• 174 Bring P, "Does oxcarbazepine warrant therapeutic drug monitoring? A critical review" 47 : 767-778, 2008
• 175 DeLuccia FJ, "Direct serum injection with micellar liquid chromatography for therapeutic drug monitoring" 57 : 1564-1568, 1985
• 176 Deng C, "Development of water-phase derivatization followed by solid-phase microextraction and gas chromatography/mass spectrometry for fast determination of valproic acid in human plasma" 20 : 1281-1287, 2006
• 177 Amini H, "Development and validation of a sensitive assay of vaproic acid in human plasma by high-performance liquid chromatography without prior derivatization" 830 : 368-371, 2006
• 178 Yu D, "Determination of vaproic acid and its metabolites using gas chromatography with mass-selective detection: application to serum and urine samples from sheep" 666 : 269-281, 1995
• 179 Xiao H, "Determination of valproic acid level in serum by high performance liquid chromatography" 16 : 365-366, 1998
• 180 Liu H, "Determination of valproic acid by high-performance liquid chromatography with photodiode-array and fluorescence detection" 576 : 163-169, 1992
• 181 Flesch G, "Determination of the R-(−) and S-(＋) enantiomers of the monohydroxylated metabolite of oxcarbazepine in human plasma by enantioselective high-performance liquid chromatography" 581 : 147-151, 1992
• 182 Haegele KD, "Determination of the R(−)- and S(＋)-enantiomers of γ-vinyl-γ-aminobutyric acid in human body fluids by gas chromatography-mass spectrometry" 274 : 103-110, 1983
• 183 "Determination of plasma topiramate concentration using LC-MS/MS for pharmacokinetic and bioequivalence studies in healthy Korean volunteers" JOHN WILEY & SONS LTD 22 : 822-829, 2008
• 184 Dzegoev AB, "Determination of phenobarbital by polarized fluoroimmunoanalysis. The effect of immunogen structure and tracer on specificity and detection limit" 19 : 713-721, 1993
• 185 Guo T, "Determination of levetiracetam in human plasma/serum/saliva by liquid chromatography-electrospray tandem mass spectrometry" 375 : 115-118, 2007
• 186 Martens-Lobenhoffer J, "Determination of levetiracetam in human plasma with minimal sample pretreatment" 819 : 197-200, 2005
• 187 Jain D, "Determination of levetiracetam in human plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to bioequivalence studies" 20 : 2539-2547, 2006
• 188 Hallbach J, "Determination of lamotrigine, carbamazepine and carbamazepine epoxide in human serum by gas chromatography mass spectrometry" 35 : 755-759, 1997
• 189 Queiroz ME, "Determination of lamotrigine simultaneously with carbamazepine, carbamazepine epoxide, phenytoin, Phenobarbital, and primidone in human plasma by SPME-GC-TSD" 40 : 219-223, 2002
• 190 Cheng CL, "Determination of lamotrigine in small volumes of plasma by high-performance liquid chromatography" 817 : 199-206, 2005
• 191 Vidal E, "Determination of lamotrigine in human serum by liquid chromatography" 736 : 295-298, 1999
• 192 Lee W, "Determination of lamotrigine in human serum by high-performance liquid chromatography-tandem mass spectrometry" 31 : 717-720, 2010
• 193 Wolf CE, "Determination of gabapentin in serum using solid-phase extraction and gas-liquid chromatography" 20 : 498-501, 1996
• 194 Ji HY, "Determination of gabapentin in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry" John Wiley & Sons Inc. 20 (20): 2127-2132, 2006
• 195 Sagirli O, "Determination of gabapentin in human plasma and urine by high-performance liquid chromatography with UV-vis detection" 42 : 618-624, 2006
• 196 Liu H, "Determination of free valproic acid: evaluation of the Centrifree system and comparison between high-performance liquid chromatography and enzyme immunoassay" 4 : 513-521, 1992
• 197 Sánchez A, "Determination of free serum carbamazepine by protein precipitation with sulphosalicylic acid" 5 : 435-438, 1999
• 198 Chollet DF, "Determination of antiepileptic drugs in biological materials" 767 : 191-233, 2002
• 199 Saka K, "Determination of amobarbital and phenobarbital in serum by gas chromatography-mass spectrometry with addition of formic acid to the solvent" 869 : 9-15, 2008
• 200 Paasch BD, "Determination of Ro 48-3656 in rat plasma by reversed-phase high-performance liquid chromatography: Comparison of 1.5-μm nonporous silica to 3.5-μm porous silica analytical columns" 704 : 231-242, 1997
• 201 Miles MV, "Determination of N-desmethylmethsuximide serum concentrations using enzyme-multiplied and fluorescence polarization immunoassays" 11 : 337-342, 1989
• 202 Maurer HH, "Detection of anticonvulsants and their metabolites in urine within a "general unknown" analysis procedure using computerized gas chromatography-mass spectrometry" 64 : 554-561, 1990
• 203 Curatolo P, "Current management for epilepsy in tuberous sclerosis complex" 19 : 119-123, 2006
• 204 Kugler AR, "Cross-reactivity of fosphenytoin in two human plasma phenytoin immunoassays" 44 : 1474-1480, 1998
• 205 Ryan M, "Correlation of levetiracetam concentrations between serum and saliva" 25 : 61-66, 2003
• 206 Hirsch LJ, "Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy" 63 : 1022-1026, 2004
• 207 Glauser TA, "Controversies in blood-level monitoring; re-examining its role in the treatment of epilepsy" 41 : 6-15, 2000
• 208 Kalbe K, "Competitive binding enzyme immunoassay for zonisamide, a new antiepileptic drug, with selected paired- enzyme labeled antigen and antibody" 36 : 24-27, 1999
• 209 Berry DJ, "Comparison of topiramate concentrations in plasma and serum by fluorescence polarization immunoassay" 22 : 460-464, 2000
• 210 Rosenfeld WE, "Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy" 38 : 324-333, 1997
• 211 Rambeck B, "Comparison of phenytoin and carbamazepine serum concentrations measured by high-performance liquid chromatography, the standard TDx assay, the enzyme multiplied immunoassay technique, and a new patient-side immunoassay cartridge system" 16 : 608-612, 1994
• 212 Carl GF, "Comparison of fluorescent immunoassay and EMIT for assay of serum primidone concentration" 4 : 325-328, 1982
• 213 Chen K, "Comparative analysis of antiepileptic drugs by gas chromatography using capillary or packed columns and by fluorescence polarization immunoassay" 15 : 82-85, 1991
• 214 Cavedal LE, "Clonazepam quantification in human plasma by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry in a bioequivalence study" 42 : 81-88, 2007
• 215 Aylett SE, "Clobazam toxicity in a child with epilepsy related to idiosyncratic metabolism" 48 : 612-615, 2005
• 216 LeGatt DF, "Clobazam and norclobazam quantitation in serum by capillary gas chromatography with electron-capture detection" 26 : 159-163, 1993
• 217 May TW, "Clinical pharmacokinetics of oxcarbazepine" 42 : 1023-1042, 2003
• 218 Patsalos PN, "Clinical pharmacokinetics of levetiracetam" 43 : 707-724, 2004
• 219 McLean MJ, "Clinical pharmacokinetics of gabapentin" 44 : 17-22, 1994
• 220 Hvidberg EF, "Clinical pharmacokinetics of anticonvulsants" 1 : 161-188, 1976
• 221 Drummer OH, "Chromatographic screening techniques in systematic toxicological analysis" 733 : 27-45, 1999
• 222 Gur P, "Chromatographic procedures for the determination of felbamate in serum" 19 : 499-503, 1995
• 223 Coulter DA, "Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons" 25 : 582-593, 1989
• 224 Franco V, "Changes in lamotrigine pharmacokinetics during pregnancy and the puerperium" 30 : 544-547, 2008
• 225 Drouet-Coassolo C, "Capillary gas chromatographic-mass spectrometric method for the identification and quantification of some benzodiazepines and their unconjugated metabolites in plasma" 487 : 295-311, 1989
• 226 Kataoka Y, "Capillary electrophoresis for therapeutic drug monitoring of antiepileptics" 19 : 2856-2860, 1998
• 227 Agarwal S, "Bioequivalence of two commercial preparations of escitalopram oxalate/clonazepam using a liquid chromatography-electrospray mass spectrometry method" 58 : 551-556, 2008
• 228 Allain P, "Automated fluoroimmunoassay of theophylline and valproic acid by flow-injection analysis with use of HPLC instruments" 35 : 469-470, 1989
• 229 Bruckner H, "Automated enantioseparation of amino acids by derivatization with o-phthaldialdehyde and N-acylated cysteines" 476 : 73-82, 1989
• 230 Holland ML, "Automated capillary gas chromatographic assay using flame ionization detection for the determination of topiramate in plasma" 433 : 276-281, 1988
• 231 Armijo JA, "Association between patient age and gabapentin serum concentration-to-dose ratio: a preliminary multivariate analysis" 26 : 633-637, 2004
• 232 Grove J, "Assay of γ-vinyl-γ-aminobutyric acid (4-amino-hex-5-enoic acid) in plasma and urine by automatic amino acid analysis: application to human pharmacokinetics" 306 : 383-387, 1984
• 233 Aucamp AK, "Aspects of the pharmacokinetics and pharmcodynamics of benzodiazepines with particular reference to clobazam" 1 : 117-126, 1982
• 234 Buchthal F, "Aspects of pharmacology of phenytoin (Dilantin) and phenobarbital relevant to their dosage in the treatment of epilepsy" 1 : 373-384, 1960
• 235 Patsalos PN, "Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommision on therapeutic drug monitoring, ILAE commission on therapeutic strategies" 49 : 1239-1276, 2008
• 236 Burton ME, "Antiepileptic drugs, In Applied pharmacokinetics & pharmacodynamics - principles of therapeutic drug monitoring. 4th ed." Lippincott Williams & Wilkins 491-, 2006
• 237 Watelle M, "Analysis of the antiepileptic phenyltriazine compound lamotrigine using gas chromatography with nitrogen phosphorus detection" 19 : 460-464, 1997
• 238 Akerman KK, "Analysis of clobazam and its active metabolite norclobazam in plasma and serum using HPLC/DAD" 56 : 609-614, 1996
• 239 Oh E, "Analysis of carbamazepine and its active metabolite, carbamazepine-10,11-epoxide, in human plasma using high-performance liquid chromatography" SPRINGER HEIDELBERG 386(6) : 1931-1936, 2006
• 240 Tang PH, "An improved gas chromatography assay for topiramate monitoring in pediatric patients" 22 : 195-201, 2000
• 241 Yang X, "An ImmunoChip prototype for simultaneous detection of antiepileptic drugs using an enhanced one-step homogeneous immunoassay" 365 : 222-229, 2007
• 242 Keränen T, "Absence of interaction between oxcarbazepine and erythromycin" 86 : 120-123, 1992
• 243 Zhang Y, "A tandem mass spectrometry assay for the simultaneous determination of acetaminophen, caffeine, phenytoin, ranitidine, and theophylline in small volume pediatric plasma specimens" 398 : 105-112, 2008
• 244 Sghendo L, "A sensitive gas chromatographic/mass spectrometric method for the resolution and quantification of ethosuximide enantiomers in biological fluids" 772 : 307-315, 2002
• 245 Stewart BH, "A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma" 10 : 276-281, 1993
• 246 Mazzucchelli I, "A novel enantioselective microassay for the high-performance liquid chromatography determination of oxcarbazepine and its active metabolite monohydroxycarbazepine in human plasma" 29 : 319-324, 2007
• 247 Heideloff C, "A novel HPLC method for quantification of 10 antiepileptic drugs or mewtabolites in serum/plasma using a monolithic column" 32 : 102-106, 2010
• 248 Ratnaraj N, "A high-performance liquid chromatography micromethod for the simultaneous determination of vigabatrin and gabapentin in serum" 20 : 430-434, 1998
• 249 Leite CE, "A high-performance liquid chromatography method for the determination of carbamazepine and carbamazepine-10,11- epoxide and its comparison with chemiluminescent immunoassay" 47 : 458-463, 2009
• 250 Booker HE, "A clinical study of serum primidone levels" 11 : 395-402, 1970
• 251 Riffitts JM, "A capillary gas chromatographic assay with nitrogen phosphorus detection for the quantification of topiramate in human plasma, urine and whole blood" 19 : 363-371, 1999
• 252 Ramael S, "A Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects" 28 : 734-744, 2006
• 253 Carrier DJ, ""In-source" fragmentation of an isobaric impurity of lamotrigine for its measurement by liquid chromatography tandem mass spectrometry after pre-concentration using solid phase extraction" 47 : 731-737, 2008